Novavax Inc (NVAX)
12.58
-0.32
(-2.48%)
USD |
NASDAQ |
May 16, 10:12
Novavax Gross Profit Margin (Quarterly): 36.91% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 36.91% |
December 31, 2023 | 38.84% |
September 30, 2023 | -348.4% |
June 30, 2023 | 86.86% |
March 31, 2023 | |
December 31, 2022 | 36.85% |
September 30, 2022 | 30.83% |
June 30, 2022 | -45.80% |
March 31, 2022 | 97.49% |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 50.97% |
June 30, 2014 | 38.22% |
March 31, 2014 | 59.51% |
December 31, 2013 | |
September 30, 2013 | 52.60% |
June 30, 2013 | 53.78% |
March 31, 2013 | 55.34% |
December 31, 2012 | 57.25% |
September 30, 2012 | 33.43% |
June 30, 2012 | 27.95% |
March 31, 2012 | 18.44% |
December 31, 2011 | 44.57% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-348.4%
Minimum
Sep 2023
97.49%
Maximum
Mar 2022
-8.30%
Average
36.88%
Median
Gross Profit Margin (Quarterly) Benchmarks
Pfizer Inc | 77.29% |
Moderna Inc | 42.52% |
Sensus Healthcare Inc | 62.48% |
Agilent Technologies Inc | 54.76% |
BioCryst Pharmaceuticals Inc | 98.50% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -24.81% |
Profit Margin (Quarterly) | -157.2% |
Operating Margin (Quarterly) | -154.3% |
Return on Net Operating Assets | -48.63% |